Opus Genetics, Inc. (IRD) Financials

IRD Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 93.0 million 106.0 million
March 31, 2026 66.8 million 112.6 million
Dec. 31, 2025 50.2 million 34.9 million
Sept. 30, 2025 36.1 million 30.2 million

IRD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -12.0 million 1.4 million
March 31, 2026 -12.7 million 1.5 million
Dec. 31, 2025 -9.8 million 774000
Sept. 30, 2025 -6.2 million 816000

IRD Net Income

No data available :(

IRD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 88.8 million 34.9 million -
March 31, 2026 60.0 million 25.9 million -
Dec. 31, 2025 45.1 million - -
Sept. 30, 2025 30.8 million 1.1 million -

IRD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 111.4 million
March 31, 2026 868.9 million
Dec. 31, 2025 622.2 million
Sept. 30, 2025 70.6 million

IRD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 11.2 million 6.0 million -
March 31, 2026 - 10.6 million 5.9 million -
Dec. 31, 2025 - 10.4 million 4.9 million -
Sept. 30, 2025 - 6.4 million 5.0 million -

IRD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 755000 -
March 31, 2026 2.2 million 13000
Dec. 31, 2025 3.9 million 13000
Sept. 30, 2025 3.1 million 13000

IRD

Price: $4.20

52 week price:
1.04
5.81

Earnings Per Share: -1.29 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 300.3 million

Links: